R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature

PURPOSE: R-CHOP (rituximab with cyclophosphamide, doxorubicin, vincristine and prednisone) and R-CVP (rituximab with cyclophosphamide, vincristine and prednisone) have both been used successfully in the treatment of patients with symptomatic follicular lymphoma (FL). No study has compared the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddhartha, Ganguly, Vijay, Patel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669150/
https://www.ncbi.nlm.nih.gov/pubmed/19309523
http://dx.doi.org/10.1186/1756-8722-2-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669150/
https://www.ncbi.nlm.nih.gov/pubmed/19309523
http://dx.doi.org/10.1186/1756-8722-2-14

Ejemplares similares